Willow Biosciences Inc
TSX:WLLW

Watchlist Manager
Willow Biosciences Inc Logo
Willow Biosciences Inc
TSX:WLLW
Watchlist
Price: 0.17 CAD Market Closed
Market Cap: 107m CAD

Willow Biosciences Inc
Investor Relations

Willow Biosciences, Inc. is a biotechnology company. The company is headquartered in Calgary, Alberta and currently employs 49 full-time employees. The company went IPO on 2017-09-14. The firm's products include tetrahydrocannabinol (THC), cannabidiol (CBD), cannabidivarin (CBDV), cannabigerovarin (CBGV), tetrahydrocannabivarin (THCV) and cannabinol (CBN). The firm has two laboratories for research and development in Mountain View, California and Burnaby, British Columbia. In addition, the Company has an analytical testing lab in Burnaby where it provides third-party analytical testing and product development services to the cannabis industry through its subsidiary Willow Analytics Inc. The company also offers testing for all forms of cannabis products, including flower, concentrates and extracted ingredients.

Show more
Loading
WLLW
S&P TSX Composite Index (Canada)
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Travis Doupe
Chief Financial Officer
No Bio Available
Dr. Chris Savile
President, Director & CEO
No Bio Available
Mr. Sanjib Singh Gill L.L.B.
Corporate Secretary
No Bio Available

Contacts

Address
ALBERTA
Calgary
202, 1201 5th Street SW
Contacts
+14039105140.0
www.willowbio.com